Among the many antitumor effects of ICOS reported, it has been observed that higher levels improve patient prognosis in lung adenocarcinoma and are associated with the inhibition of tumor progression and a healthier tumor immune microenvironment (enriched T cell numbers and improved ImmuneScore and ESTIMATEscore) [34]. This evidence concerns the gene ICOS and lung adenocarcinoma.